跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
在 國立陽明交通大學研發優勢分析平台 搜尋內容
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
Phase II Study of the Modified Regimen of Etoposide, Leucovorin and 5-Fluorouracil for Patients with Advanced Gastric Cancer
Tzeon Jye Chiou
*
, Shiao Lin Tung
, Ruey Kuen Hsieh
,
Wei Shu Wang
, Chueh Chuan Yen
, Frank S. Fan
, Jin Hwang Liu
, Po Min Chen
*
此作品的通信作者
醫學系內科學科
生物藥學研究所
研究成果
:
Article
›
同行評審
8
引文 斯高帕斯(Scopus)
總覽
指紋
指紋
深入研究「Phase II Study of the Modified Regimen of Etoposide, Leucovorin and 5-Fluorouracil for Patients with Advanced Gastric Cancer」主題。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
5-fluorouracil (5-FU)
100%
Advanced Gastric Cancer
100%
Advanced or Metastatic
33%
Alopecia
16%
Chemotherapy
33%
Combination Regimen
16%
Complete Response
16%
Confidence Interval
16%
Dose Intensity
16%
Duration of Response
16%
Etoposide
100%
Gastric Cancer Patients
16%
Leucovorin
100%
Median Survival Time
16%
Metastatic Gastric Cancer
33%
Modified Treatment
100%
Myelosuppression
16%
Nave
16%
Overall Median Survival
16%
Overall Response Rate
16%
Phase II Study
100%
Progression-free Interval
16%
Response Rate
16%
Tolerable Side Effects
16%
Treatment-related Mortality
16%
Tumor Response
16%
WHO Criteria
16%
Pharmacology, Toxicology and Pharmaceutical Science
Abdominal Cancer
100%
Alopecia
16%
Bone Marrow Suppression
16%
Chemotherapy
33%
Diseases
33%
Etoposide
100%
Fluorouracil
100%
Folinic Acid
100%
Median Survival Time
16%
Neoplasm
16%
Progression Free Survival
16%
Side Effect
33%